omeprazole, amoxicillin, and rifabutin · Talicia

Small molecule

Also known as RHB-105

Approvedregulatory verdict

Evidence outlook

Approved: Helicobacter pylori Infection

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Reliable signal

Also approved (1)
AE
  • Helicobacter pylori infection (Talicia, omeprazole magnesium, amoxicillin and rifabutin)
Product first approved 2023biospace.com

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (2)
Helicobacter pylori Infection

Competitive landscape

This drug's own stage for Helicobacter pylori Infection: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Omeprazole, Amoxicillin, And Rifabutin (Talicia): this drugApprovedSmall moleculeH. pylori eradication (PPI + amoxicillin + rifabutin)Reliable signal
NCT03198507: Number of Participants With Eradication of H. Pylori (43-71 days after initiation of treatment): RHB-105 191 Participants | Active Comparator 131 Participants
NCT01980095: The Occurrence of H. Pylori Eradication as Confirmed Via 13C UBT Testing (28-56 days after completion of treatment): RHB-105 — H. pylori eradication success: 59 Participants; H. pylori eradication failure: 7 Participants | Placebo — H. pylori eradication success: 1 Participants; H. pylori eradication failure: 36 Participants
Esomeprazole (Nexium)ApprovedSmall moleculeH+/K+-ATPase (gastric proton pump)not yet gradedNo reviewed efficacy summary in this indication
Rabeprazole (Aciphex)ApprovedSmall moleculeH+/K+-ATPase (gastric proton pump)not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

No upcoming readouts on record for this asset.